SYNT vs. VCT, SCPA, ESNT, TET, ZTF, IOF, WCH, ITX, DCTA, and HDD
Should you be buying Synthomer stock or one of its competitors? The main competitors of Synthomer include Victrex (VCT), Scapa Group (SCPA), Essentra (ESNT), Treatt (TET), Zotefoams (ZTF), Iofina (IOF), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), and Hardide (HDD). These companies are all part of the "specialty chemicals" industry.
Synthomer vs.
Synthomer (LON:SYNT) and Victrex (LON:VCT) are both small-cap basic materials companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, community ranking, media sentiment, dividends, valuation, analyst recommendations and profitability.
Victrex has a net margin of 10.81% compared to Synthomer's net margin of -4.40%. Victrex's return on equity of 6.67% beat Synthomer's return on equity.
In the previous week, Synthomer and Synthomer both had 2 articles in the media. Victrex's average media sentiment score of 0.70 beat Synthomer's score of 0.12 indicating that Victrex is being referred to more favorably in the news media.
Synthomer presently has a consensus target price of GBX 251.67, suggesting a potential upside of 91.24%. Victrex has a consensus target price of GBX 1,425, suggesting a potential upside of 51.92%. Given Synthomer's stronger consensus rating and higher possible upside, analysts plainly believe Synthomer is more favorable than Victrex.
Synthomer has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, Victrex has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500.
Synthomer received 220 more outperform votes than Victrex when rated by MarketBeat users. Likewise, 68.52% of users gave Synthomer an outperform vote while only 63.61% of users gave Victrex an outperform vote.
Victrex has lower revenue, but higher earnings than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Victrex, indicating that it is currently the more affordable of the two stocks.
Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 19.0%. Victrex pays an annual dividend of GBX 60 per share and has a dividend yield of 6.4%. Synthomer pays out -50.1% of its earnings in the form of a dividend. Victrex pays out 170.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.
43.8% of Synthomer shares are owned by institutional investors. Comparatively, 97.1% of Victrex shares are owned by institutional investors. 28.0% of Synthomer shares are owned by company insiders. Comparatively, 1.6% of Victrex shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Synthomer beats Victrex on 10 of the 19 factors compared between the two stocks.
Get Synthomer News Delivered to You Automatically
Sign up to receive the latest news and ratings for SYNT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Synthomer Competitors List
Related Companies and Tools
This page (LON:SYNT) was last updated on 2/22/2025 by MarketBeat.com Staff
